SYSMEX XN 1000 CAN PREDICT THE TIME OF STEM CELL COLLECTION WITH NEW COMPLETE BLOOD COUNT PARAMETERS: SINGLE CENTER EXPERIENCE FROM TURKEY

EHA Library, Eren Gunduz, 324446

PATIENT-CENTERED FACTORS IN EVALUATION OF ELIGIBILITY AND PROGNOSTICATION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION IN OLDER PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A SYSTEMATIC REVIEW

EHA Library, Stefan Koeck, 324448

IS THE USE OF DEFIBROTID EFFECTIVE ON GRAFT VERSUS DISEASE (GVHD) IN ALLOGENEIC STEM CELL TRANSPLANTATION?

EHA Library, Atakan Turgutkaya, 324449

CLINICO-HEMATOLOGICAL PREDICTORS OF RESPONSE DEEPENING AFTER STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Ivan Kostroma, 324450

A PHASE 2 OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY OF RUXOLITINIB ADDED TO CORTICOSTEROIDS IN PEDIATRIC SUBJECTS WITH MODERATE/SEVERE CHRONIC GVHD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (REACH5)

EHA Library, Cristina Diaz-de-Heredia, 324451

EFFECT OF CYP3A5 GENE POLYMORPHISMS ON TACROLIMUS CONCENTRATION AND ADVERSE EVENTS IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL

EHA Library, Xin Chen, 324452

ANTIGENIC DIVERSITY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX AMONG RECIPIENTS, RELATED DONORS AND HEMATOPOIETIC STEM CELL DONORS OF THE REGISTRY OF THE REPUBLIC OF BELARUS

EHA Library, Alena Hlaz, 324453

COMPARATIVE EFFECTIVENESS OF DIFFERENT CONDITIONING REGIMENS WHEN PERFORMING AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS

EHA Library, Ivan Kostroma, 324454

USE OF RECOMBINANT SUPEROXIDE DISMUTASE IS THE EFFECTIVE METHOD TO REDUCE TOXIC COMPLICATIONS IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Ivan Kostroma, 324455

THE RESULTS OF THERAPY IN PATIENTS WITH B-CELL LYMPHOID MALIGNANCIES WITH MUTATIONS IN THE TP53 GENE

EHA Library, Evgeniy Zvonkov, 324456

PREEMPTIVE VS SALVAGE RUXOLITINIB TREATMENT FOR STEROID-INSENSITIVE ACUTE GRAFT-VERSUS-HOST-DISEASE (SI-AGVHD): WHICH APPROACH IMPROVES CLINICAL OUTCOMES?

EHA Library, Ting Yang, 324457

BORTEZOMIB + HIGH-DOSE MELPHALAN (BORMEL200) VERSUS MEL200 AS A CONDITIONING REGIMEN FOR AUTOLOGOUS HEMATOPOIETIC PROGENITORS TRANSPLANTATION (TAPH) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM).

EHA Library, María Irene Nuevo López, 324458

RESULTS OF SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL DISEASES: RETROSPECTIVE ANALYSIS OF OUR HOSPITAL

EHA Library, Elena Paumard Rodríguez, 324459

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR CHRONIC GRANULOMATOUS DISEASE: A SINGLE-CENTER 10-YEAR RETROSPECTIVE SERIES

EHA Library, Ana Isabel Marques, 324460

EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF ACUTE OR CHRONIC GRAFT VERSUS HOST DISEASE (GVHD) IN PEDIATRIC PATIENTS: MONOCENTRIC EXPERIENCE

EHA Library, Danilo De Novellis, 324461

BENDAMUSTINE IMMEDIATELY BEFORE MOBILIZATION MAY DIFFICULT THE COLLECTION OF HEMATOPOIETIC STEM CELLS IN LYMPHOMA.

EHA Library, Mariana Bastos Oreiro, 324462

COMPARISON OF VIABILITY AND HEMATOLOGIC RECOVERY AFTER ALLOGENEIC TRANSPLANTATIONS WITH FRESH OR FROZEN IN 5% DIMETHYLSULPHOXIDE (DMSO) HEMATOPOIETIC STEM CELLS (HSC)

EHA Library, Ivan Tonev, 324463

ESTABLISHING A TRANSPLANT SHARING PROGRAM

EHA Library, I Luts Khoroz, 324464

ECULIZUMAB FOR TREATMENT OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY IN OUR CENTRE

EHA Library, Paula Maria Garcia Cereijo, 324465

A SINGLE SUBCUTANEOUS INJECTION OF PLERIXAFOR IN COMBINATION WITH G-CSF INCREASE THE MOBILIZATION EFFICIENCY AND FACILITATE THE CELLULAR PHENOTYPING AND FUNCTION OF HEMATOPOIETIC STEM CELLS

EHA Library, Ting Yang, 324466

OUTCOME OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH A DONOR AND RECIPIENT WITH SARS-COV2 INFECTION.

EHA Library, Gadallah Ali, 324467

LOW-DOSE PTCY PLUS HAPLO-INDENTICAL TRANSPLANTATION A FEASIBLE AND SAFE CONSOLIDATION STRATEGY FOR CAR T-CELL SALVAGED REFRACTORY/RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA------THREE CASE REPORT

EHA Library, xm fei, 324468

DONOR LYMPHOCYTE INFUSION (DLI). A STRATEGY TO PREVENT OR TREAT RELAPSE FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION. ONE SINGLE CENTER EXPERIENCE.

EHA Library, Paula Fernández-Caldas González, 324469

CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT OF GRAFT VERSUS HOST DISEASE (GVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

EHA Library, Ana Puchol, 324470

EFFECT OF THE DURATION OF CRYOPRESERVATION ON THE VIABILITY AND PROLIFERATIVE POTENTIAL OF HSCS DURING AUTOGRAFT HARVESTING IN PATIENTS WITH MM

EHA Library, Natalya Semenova, 324471

CYCLOSPORINE CAN INHIBIT INTESTINAL AGVHD BY REGULATING MITOCHONDRIAL APOPTOSIS

EHA Library, Sumei Li, 324472

NEXT-GENERATION SEQUENCING-DEFINED MINIMAL RESIDUAL DISEASE AT THE STEM/PROGENITOR CELL LEVEL PREDICT POST-TRANSPLANTATION RELAPSE IN ACUTE MYELOID LEUKEMIA

EHA Library, Fei Zhao, 324473

THE STUDY OF MICRORNAS IN CD34+ HSPCS FROM AML PATIENTS WITH RELAPSE AFTER ALLOGENEIC TRANSPLANTATION

EHA Library, Fei Zhao, 324474

HEMOGLOBINOPATHIES AND COVID-19: THE EXPERIENCE OF A CENTER IN NORTHERN GREECE

EHA Library, Christos Varelas, 324475

ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

EHA Library, Kevin H.M. Kuo, 324476

DESIGN AND DEVELOPMENT OF A MACHINE LEARNING-BASED PREDICTIVE MODELLING TOOL TO ACCURATELY PREDICT THALASSEMIA CARRIER STATE USING FULL BLOOD COUNT INDICES AND HAEMOGLOBIN VARIANTS

EHA Library, C.A.D.M.N.C. Kolambage, 324477

RETROSPECTIVE ANALYSIS OF OGTT IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSEMIA DURING THEIR SECOND DECADE OF LIFE

EHA Library, Marina Economou, 324478

MCV VARIATION AS AN EARLY PREDICTOR OF RESPONSE TO LUSPATERCEPT IN NTDT PATIENTS: PRELIMINARY DATA

EHA Library, Andrea Piolatto, 324479

THE PATIENTS WITH THALASSEMIA MAJOR MAY STILL DISPLAY GROWTH HORMONE DEFICIENCY DESPITE OPTIMUM TRANSFUSION AND IRON CHELATION THERAPY.

EHA Library, Yesim Aydinok, 324480

THE USE OF HYDROXYUREA IN THE REAL LIFE OF MIOT NETWORK: AN OBSERVATIONAL STUDY

EHA Library, Antonella Meloni, 324481

MICRO-RNA 451 EXPRESSION AS A HEMOLYTIC MARKER IN EGYPTIAN CHILDREN WITH BETA-THALASSEMIA

EHA Library, Yasmine El Chazli, 324482

CHELATION THERAPY WITH THE TWO DEFERASIROX FORMULATIONS IN TRANSFUSION-DEPENDENT THALASSEMIA CHILDREN OVER THE PAST TWO DECADES: A SINGLE CENTER EXPERIENCE

EHA Library, Alkistis Adramerina, 324483

ROLE OF TELEMEDICINE IN MANAGEMENT OF ADULT EGYPTIAN THALASSAEMIA PATIENTS DURING COVID-19 PANDEMIC; PATIENTS SURVEY

EHA Library, Rasha Rawi, 324484

DISTINCTION BETWEEN IRON DEFICIENCY ANEMIA AND MINOR Β-THALASSEMIA: DETERMINATION OF CUT-OFF OPTIMAL VALUES OF TEN HEMATOLOGICAL FORMULAS

EHA Library, Mayssa Ben Ayed, 324485

USE OF RED BLOOD CELL AND RETICULOCYTE PARAMETERS FOR THE SCREENING OF MICROCYTIC ANAEMIA

EHA Library, Anne-Sophie Adam, 324486

IMMUNE PROFILE EVALUATION IN PEDIATRIC PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA

EHA Library, Marina Economou, 324487

KNOWLEDGE ON THALASSAEMIA AMONG STUDENTS AGED BETWEEN 14-17YRS IN KURUNEGALA DISTRICT, SRI LANKA

EHA Library, Rohinie Warushahennadi, 324488

GENETIC VARIATIONS OF IRON REGULATORY PROTEINS: FERROPORTIN-1(-8CG), TMPRSS6 (RS855791) AND HEMOJUVELIN (I222N AND G320V) WITHIN Β-THALASSEMIA MAJOR PATIENTS

EHA Library, Iman Shaheen, 324489

HB MARUCHI [ΑLPHA165 (E14) ALA> PRO; HBA1: C.196G> C]: A NEW THALASSEMIA HEMOGLOBINOPATHY RELATED TO THE ALPHA1 GLOBIN GENE

EHA Library, Paloma Ropero, 324490

EVALUATION OF IMMUNE FUNCTIONS IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS WITH ALLOIMMUNIZATION

EHA Library, Tuba Hilkay Karapınar, 324491

A RARE CASE OF SEVERE ANAEMIA SINCE BIRTH: HAEMOGLOBIN AGRINIO.

EHA Library, Marta Moreno Carbonell, 324492

DIAGNOSIS OF THROMBOPHILIA IN YOUNG PATIENTS AND THE EFFICIENCY OF SECONDARY PREVENTION OF THROMBOSIS WITH DIRECT ORAL ANTICOAGULANTS

EHA Library, Valery Voitsekhovsky, 324493

EFFECTS OF DIABETES MELLITUS ON HEMOSTATIC CHANGES, A SYSTEMATIC REVEW

EHA Library, Artur Temizio Oppelt Raab, 324494

EVALUATION OF D-DIMERS CONCENTRATIONS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS SURGERY

EHA Library, Mahjoub Sonia, 324495

A RARE CASE OF BI-ATRIAL THROMBI IN A STAGE IV PANCREATIC CANCER PATIENT WITH ATRIAL FIBRILLATION ON WARFARIN

EHA Library, Na Kim, 324496

EXPERIENCE IN THE USE OF BIOSIMILAR ENOXAPARIN SODIUM FOR PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE IN OUR HOSPITAL

EHA Library, Maria Almudana Garcia Ruiz, 324497

STUDIES OF GEOGRAPHIC VARIATIONS IN RISK FACTORS ASSOCIATED WITH THROMBOPHILIA AND ITS POSSIBLE IMPACT ON DISEASE MANAGEMENT PLANNING

EHA Library, Sarah AlMukhaylid, 324498

THE USEFUL OF TESTING DIRECT ORAL ANTICOAGULANTS

EHA Library, Carlos Martinez, 324499

DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN AN ADOLESCENT WITH SARS-COV-2 INFECTION

EHA Library, Athina Dettoraki, 324500

COVID-19 ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) ; A CASE SERIES AND MINI-REVIEW

EHA Library, Hamed Azhdari Tehrani, 324501

A YOUNG WOMEN WITH LIGNEOUS MEMBRANES WHO WANTS TO BE PREGNANT

EHA Library, Ayse Gonca Kacar, 324503

AN AUDIT OF DIAGNOSIS AND MANAGEMENT OF PE IN DGH AND LITERATURE REVIEW.

EHA Library, Tariq Memon, 324504

ERYTHROCYTE AND PLATELET TRANSFUSION PRACTISES IN PEDIATRIC HEMATOLOGY AND ONCOLOGY PATIENTS AND INVESTIGATION OF THEIR EFFECTS ON OUTCOME

EHA Library, Hale Ören, 324505

FREQUENCY OF DIFFERENT BLOOD GROUPS AND ITS ASSOCIATION WITH BODY MASS INDEX AND BLOOD PRESSURE AMONG TWO-THOUSAND-EIGHT-HUNDRED-EIGHTY-THREE BLOOD DONORS

EHA Library, Talbi Faiza, 324506

THE PREVALENCE OF MNS, KIDD, DUFFY BLOOD GROUP SYSTEMS PHENOTYPES IN BLOOD DONORS LIVING IN THE EUROPEAN PART OF RUSSIAN FEDERATION

EHA Library, Anna Yovdiy, 324507

PIGA GERMLINE MUTATIONS CAUSE DECREASED HEPCIDIN EXPRESSION AND A NOVEL SUBTYPE OF HEREDITARY HEMOCHROMATOSIS

EHA Library, Oriana Marques, 324508

THE BEYOND STUDY: RESULTS OF A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF LUSPATERCEPT IN ADULT PATIENTS WITH NON-TRANSFUSION DEPENDENT BETA-THALASSEMIA

EHA Library, Ali T. Taher, 324509

HEMATOPOIETIC STEM CELL-GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE I, HURLER: EVIDENCE OF EXTENSIVE METABOLIC CORRECTION AND EARLY CLINICAL RESPONSE

EHA Library, Maria Ester Bernardo, 324510

PAZOPANIB FOR SEVERE BLEEDING AND TRANSFUSION-DEPENDENT ANEMIA IN HEREDITARY HEMORRHAGIC TELANGIECTASIA

EHA Library, Hanny Al-Samkari, 324511

A Β2 ADRENERGIC RECEPTOR AGONIST CORRECTS DYSREGULATED POLARIZATION OF T HELPER CELLS IN PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Xiao-Hui Zhang, 324512

DYSREGULATION OF CHROMATIN MODIFIERS DRIVES LINEAGE SWITCH IN MLL-R ACUTE LEUKEMIA

EHA Library, Katarzyna Szoltysek, 324513

IL7R MUTATIONAL ACTIVATION CAN INITIATE PH-LIKE AND PAX5 P80R PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, João T. Barata, 324514

BRUTON’S TYROSINE KINASE INHIBITION SENSITIZES ACUTE LYMPHOBLASTIC LEUKEMIA TO ASPARAGINASE BY INTERFERING WITH THE AMINO ACID RESPONSE - A ROLE FOR C-MYC

EHA Library, Miriam Butler, 324515

EHMT2/G9A DRIVES THE EPIGENETIC REGULATION OF GLUCOSE METABOLISM IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Anna Montanaro, 324516

INDUCIBLE RNA INTERFERENCE IN PATIENTS´ ACUTE LEUKEMIA PDX MODELS IN VIVO TO IDENTIFY AND VALIDATE THERAPEUTIC TARGETS

EHA Library, Michela Carlet, 324517

LOSS OF IKZF1 CONTRIBUTES TO CYTARABINE RESISTANCE IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Britt Vervoort, 324518

REDEFINING LOW RISK HIGH HYPERDIPLOIDY IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Anthony Moorman, 324519

UPDATED RESULTS OF THE GIMEMA LAL2116, D-ALBA TRIAL, FOR NEWLY DIAGNOSED ADULTS WITH PH+ ALL

EHA Library, Sabina Chiaretti, 324520

INTERIM RESULTS OF A PHASE II STUDY OF BLINATUMOMAB PLUS PONATINIB FOR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Nicholas Short, 324521

PRELIMINARY RESULTS OF THE GIMEMA LAL2317 SEQUENTIAL CHEMOTHERAPY-BLINATUMOMAB FRONT-LINE TRIAL FOR NEWLY DIAGNOSED ADULT PH-NEGATIVE B-LINEAGE ALL PATIENTS

EHA Library, Renato Bassan, 324522

DONOR-DERIVED CD7 CAR T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jing Pan, 324523

OUTCOMES OF CHILDREN AGED UNDER 3 YEARS TREATED WITH TISAGENLECLEUCEL FOR B-ALL

EHA Library, Sara Ghorashian, 324524

PHASE 2 RESULTS OF THE ZUMA-3 STUDY EVALUATING KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Gunjan Shah, 324525

A NOVEL CD19/CD20 DUAL SYNTHETIC T-CELL RECEPTOR AND ANTIGEN RECEPTOR (STAR) T CELL THERAPY FOR REFRACTORY AND RELAPSED (R/R) B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

EHA Library, Peihua Lu, 324526

LONG-TERM FOLLOW-UP OF SEQUENTIAL CD19-22 CAR T-CELL THERAY IN 20 CHILDREN WITH REFRACTORY OR RELAPSED B-ALL

EHA Library, Kaiting Tang, 324527

NONCODING REGULATORY LOCUS MYNRL15 MODULATES CHROMATIN ARCHITECTURE AND REPRESENTS A NOVEL MYELOID LEUKEMIA DEPENDENCY

EHA Library, Michelle Ng, 324528

HUMAN ENDOGENOUS RETROVIRUSES CHARACTERIZE THE DIFFERENT SUBPOPULATIONS OF NORMAL AND LEUKEMIC CELLS AND REPRESENT A SOURCE OF EPITOPES FOR CANCER IMMUNOTHERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Vincent Alcazer, 324529

ISOFORM-SPECIFIC AND SIGNALING-DEPENDENT PROPAGATION OF ACUTE MYELOID LEUKEMIA BY WILMS TUMOR 1

EHA Library, Constanze Bonifer, 324530

MYC SUPER-ENHANCER HIJACKING BY EVI1 IN LEUKEMIA IS CTCF DEPENDENT

EHA Library, Roger Mulet Lazaro, 324531

TET3 PROMOTES GROWTH AND EPIGENETICALLY REGULATES GLUCOSE METABOLISM AND LEUKEMIC STEM CELL ASSOCIATED PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Shiva Bamezai, 324532

RELEASE OF INTERFERON-GAMMA BY AML CELLS REMODELS BONE MARROW IMMUNE MICROENVIRONMENT BY INDUCING REGULATORY T CELLS

EHA Library, Marilena Ciciarello, 324533

INHIBITION OF CYSTINE IMPORT BY REPURPOSING OF SULFASALAZINE TO TREAT ACUTE MYELOID LEUKEMIA

EHA Library, Raphael Itzykson, 324534

FUNCTIONAL IN VIVO CHARACTERISTICS OF PDX AML SINGLE CELL CLONES PREDICT OUTCOME IN LARGE AML PATIENT COHORTS

EHA Library, Binje Vick, 324535

STANDARDIZING NGS-MRD IN AML: AN INTERNATIONAL STUDY BY THE ELN-MRD WORKING PARTY

EHA Library, Michael Heuser, 324536

ACUTE RESISTANCE TO BET INHIBITORS REMODELS COMPENSATORY TRANSCRIPTIONAL PROGRAMMES VIA P300 CO-ACTIVATION

EHA Library, Daniel Sasca, 324537

SEQUENTIAL NCRI AML TRIALS SHOW CONSISTENT BENEFIT FOR RIC TRANSPLANT IN CR1 FOR OLDER PATIENTS >60YEARS THAT IS INDEPENDENT OF MRD STATUS AFTER FIRST INDUCTION

EHA Library, Nigel Russell, 324538

SURVIVAL OUTCOMES FROM THE QUAZAR AML-001 TRIAL WITH ORAL AZACITIDINE FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN REMISSION BY DISEASE SUBTYPE, CYTOGENETIC RISK, AND NPM1 MUTATION STATUS AT DIAGNOSIS

EHA Library, Hartmut Döhner, 324539

RUNX1 MUTATIONS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA DO NOT ADVERSELY IMPACT CLINICAL OUTCOMES IN THE MODERN ERA

EHA Library, Sangeetha Venugopal, 324540

A UNIFIED CLASSIFICATION AND RISK STRATIFICATION ALGORITHM TO SUPPORT CLINICAL DECISIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Elli Papaemmanouil, 324541

A NATIONAL DANISH PROOF OF CONCEPT ON FEASIBILITY AND SAFETY OF HOME -BASED INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Kristina Nørskov, 324542

EFFICACY AND SAFETY OF VENETOCLAX IN COMBINATION WITH GILTERITINIB FOR RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA: UPDATED ANALYSES OF A PHASE 1B STUDY

EHA Library, Jessica K. Altman, 324543

A PHASE IB/II STUDY OF IVOSIDENIB WITH VENETOCLAX +/- AZACITIDINE IN IDH1-MUTATED MYELOID MALIGNANCIES

EHA Library, Curtis Lachowiez, 324544

MEASURABLE RESIDUAL DISEASE RESPONSE IN ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE

EHA Library, Keith Pratz, 324545

EFFECT OF OLUTASIDENIB (FT-2102) ON COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY MUTANT IDH1 ACUTE MYELOID LEUKEMIA. RESULTS FROM A PLANNED INTERIM ANALYSIS OF A PHASE 2 CLINICAL TRIAL

EHA Library, Stéphane De Botton, 324546

FLAVIDA CHEMOTHERAPY INDUCES MRD-NEGATIVE REMISSION IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Rabia Shahswar, 324547